Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Meta-analysis of published clinical trials showed that a regimen of oral acetylcysteine administration along with hydration reduced the relative risk of developing contrast nephropathy by 56% among patients with pre-existing renal insufficiency.

Preventing Contrast Nephropathy